(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 1. Schematic illustration of the treatment protocol. DEPV, serum and glucose deprivation; MOR, morphine; NAL, naloxone; GNTI, guanidinyl-naltrindole; NAT, natrindole; DADLE, [D-Ala2, D-Leu5]-enkephalin acetate salt; PD98059, 2'-amino-3'-methoxyflavone; U0126, 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)-butadiene; LY294002, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; GLY, glybenclamide.